Lipid Modification Database
Tag Content
LipidDB ID
LipidDB-9606-01478
Entry Name
UniProt Accession
Theoretical PI
8.47
Molecular Weight
52857.95
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
Cannabinoid receptor 1
Protein Synonyms/Alias
CB-R; CB1; CANN6;
Gene Name
CNR1
Gene Synonyms/Alias
CNR;
Created Date
01-MAY-1991
 Lipid Modification Sites 
 Position   Sequence Form   Peptide   References   Modification Type 
415
Canonical
FRSMFPSCEGTAQPL
[1]
S-Palmitoylation
Organism
Homo sapiens (Human)
NCBI Taxa ID
9606
Reference
[1] Oddi S, Dainese E, Sandiford S, Fezza F, Lanuti M, Chiurchiù V, Totaro A,Catanzaro G, Barcaroli D, De Laurenzi V, Centonze D, Mukhopadhyay S, Selent J,Howlett AC, Maccarrone M. Effects of palmitoylation of Cys(415) in helix 8 of theCB(1) cannabinoid receptor on membrane localization and signalling. Br JPharmacol. 2012 Apr;165(8):2635-51. doi: 10.1111/j.1476-5381.2011.01658.x. PubMedPMID: 21895628; PubMed Central PMCID: PMC3423250.[PMID:21895628]
Functional Description
Involved in cannabinoid-induced CNS effects. Acts by inhibiting adenylate cyclase. Could be a receptor for anandamide. Inhibits L-type Ca(2+) channel current. Isoform 2 and isoform 3 have altered ligand binding.
Sequence Annotation
Topological domain: 1 116 Extracellular.
Transmembrane: 117 142 Helical; Name=1.
Topological domain: 143 154 Cytoplasmic.
Transmembrane: 155 175 Helical; Name=2.
Topological domain: 176 187 Extracellular.
Transmembrane: 188 212 Helical; Name=3.
Topological domain: 213 232 Cytoplasmic.
Transmembrane: 233 255 Helical; Name=4.
Topological domain: 256 273 Extracellular.
Transmembrane: 274 299 Helical; Name=5.
Topological domain: 300 344 Cytoplasmic.
Transmembrane: 345 365 Helical; Name=6.
Topological domain: 366 377 Extracellular.
Transmembrane: 378 399 Helical; Name=7.
Topological domain: 400 472 Cytoplasmic.
Protein Length
472 AA.
Protein Sequence
(Canonical)
MKSILDGLAD TTFRTITTDL LYVGSNDIQY EDIKGDMASK LGYFPQKFPL TSFRGSPFQE  60
KMTAGDNPQL VPADQVNITE FYNKSLSSFK ENEENIQCGE NFMDIECFMV LNPSQQLAIA  120
VLSLTLGTFT VLENLLVLCV ILHSRSLRCR PSYHFIGSLA VADLLGSVIF VYSFIDFHVF  180
HRKDSRNVFL FKLGGVTASF TASVGSLFLT AIDRYISIHR PLAYKRIVTR PKAVVAFCLM  240
WTIAIVIAVL PLLGWNCEKL QSVCSDIFPH IDETYLMFWI GVTSVLLLFI VYAYMYILWK  300
AHSHAVRMIQ RGTQKSIIIH TSEDGKVQVT RPDQARMDIR LAKTLVLILV VLIICWGPLL  360
AIMVYDVFGK MNKLIKTVFA FCSMLCLLNS TVNPIIYALR SKDLRHAFRS MFPSCEGTAQ  420
PLDNSMGDSD CLHKHANNAA SVHRAAESCI KSTVKIAKVT MSVSTDTSAE AL          472
FASTA
(Canonical)
>LipidDB-9606-01478|P21554
MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQE
KMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIA
VLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVF
HRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLM
WTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWK
AHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLL
AIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQ
PLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
Gene Ontology
GO:0005887; C:integral component of plasma membrane; TAS:ProtInc
GO:0005886; C:plasma membrane; TAS:Reactome
GO:0004949; F:cannabinoid receptor activity; IDA:UniProtKB
GO:0008144; F:drug binding; IEA:Ensembl
GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IDA:UniProtKB
GO:0007568; P:aging; IEA:Ensembl
GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
GO:0042593; P:glucose homeostasis; IEA:Ensembl
GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
GO:0007613; P:memory; IEA:Ensembl
GO:0045759; P:negative regulation of action potential; IEA:Ensembl
GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
GO:0033602; P:negative regulation of dopamine secretion; IEA:Ensembl
GO:0031999; P:negative regulation of fatty acid beta-oxidation; IEA:Ensembl
GO:0033004; P:negative regulation of mast cell activation; IEA:Ensembl
GO:0051001; P:negative regulation of nitric-oxide synthase activity; IEA:Ensembl
GO:0002866; P:positive regulation of acute inflammatory response to antigenic stimulus; IEA:Ensembl
GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
GO:0031622; P:positive regulation of fever generation; IEA:Ensembl
GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
GO:0060259; P:regulation of feeding behavior; IEA:Ensembl
GO:0050796; P:regulation of insulin secretion; IEA:Ensembl
GO:0060405; P:regulation of penile erection; IEA:Ensembl
GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl
GO:0051966; P:regulation of synaptic transmission, glutamatergic; IEA:Ensembl
GO:0042220; P:response to cocaine; IEA:Ensembl
GO:0045471; P:response to ethanol; IEA:Ensembl
GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
GO:0043278; P:response to morphine; IEA:Ensembl
GO:0035094; P:response to nicotine; IEA:Ensembl
GO:0007584; P:response to nutrient; IEA:Ensembl
GO:0019233; P:sensory perception of pain; IEA:Ensembl
GO:0007283; P:spermatogenesis; IEA:Ensembl
Interpro
InterPro; IPR000810; Canbinoid_rcpt_1
InterPro; IPR002230; Cnbnoid_rcpt
InterPro; IPR000276; GPCR_Rhodpsn
InterPro; IPR017452; GPCR_Rhodpsn_7TM
Pfam
Pfam; PF00001; 7tm_1;
SMART
PROSITE
PROSITE; PS00237; G_PROTEIN_RECEP_F1_1;
PROSITE; PS50262; G_PROTEIN_RECEP_F1_2;
PRINTS
PRINTS; PR00522; CANABINOID1R;
PRINTS; PR00362; CANNABINOIDR;
PRINTS; PR00237; GPCRRHODOPSN;